New virus cases under 200 for 16th day; untraceable infections at worrisome level SEOUL. KAZINFORM South Korea's new coronavirus cases stayed below 200 for the 16th straight day Friday, but health authorities remained alert as sporadic cluster infections continued to rise and untraceable cases hit a fresh record high.
Global coronavirus cases top 30 mil. with 940,000 deaths: U.S. tally TOKYO. KAZINFORM The number of confirmed novel coronavirus cases worldwide surpassed the 30 million mark on Friday, with some 940,000 deaths for a mortality rate of around 3 percent, according to a tally from Johns Hopkins University in the United States.
Israel expands economic safety net to deal with upcoming full nationwide lockdown JERUSALEM. KAZINFORM - Israel expanded its COVID-19 national economic safety net program ahead of the full nationwide closure that will begin on Friday, the Prime Minister's Office and Finance Ministry said in a joint statement on Thursday night, Xinhua reports.
Celltrion's COVID-19 treatment candidate gets nod for further clinical trials SEOUL. KAZINFORM - South Korea's Ministry of Food and Drug Safety said Thursday that it has approved advanced clinical trials for Celltrion Inc.'s CT-P59 treatment material that could be used to combat the novel coronavirus, Yonhap reports.
Global coronavirus cases top 30 mil. with 940,000 deaths: U.S. tally TOKYO. KAZINFORM - The number of confirmed novel coronavirus cases worldwide surpassed the 30 million mark on Friday, with some 940,000 deaths for a mortality rate of around 3 percent, according to a tally from Johns Hopkins University in the United States, Kyodo News reports.
KHL postpones matches of Barys after positive COVID-19 tests among team members NUR-SULTAN. KAZINFORM – 6 season games of HC Barys in the Kontinental Hockey League have been postponed to a later date as 12 team and coaching staff members tested positive for the COVID-19 infection, Kazinform cites the team’s official website.
Kazakhstani COVID-19 vaccine enters clinical trials NUR-SULTAN. KAZINFORM – Clinical trials of Kazakhstani QazCovid-in vaccine against the COVID-19 virus developed by the Scientific Research Institute for Biological Safety Problems have kicked off in Kazakhstan, Kazinform cites the Telegram channel of the Ministry of Education and Science.
Researchers study Sars-CoV2 proteins in Sirius laboratory SÃO PAULO. KAZINFORM - The country’s biggest and most complex infrastructure, the Sirius, the synchroton accelerator at the National Energy and Material Research Center (CNPEM) in Campinas, São Paulo state, has been used by researchers since the beginning of September to study protein crystals of the novel coronavirus, Agencia Brasil reports.